Case series summary This case series documents five cases of pneumonia (with pleural effusion in three cases) caused by cowpox virus (CPxV) in domestic cats. Predisposition to pneumonia may have resulted from mixed infections in two cases (feline herpesvirus and Bordetella bronchiseptica in one cat, and Mycoplasma species in the other). Relevance and novel information As well as diagnostic confirmation by previously described methods of virus isolation from skin lesions, and demonstration of pox virions in skin samples using electron microscopy and inclusion bodies in histological preparations, this is the first report of diagnosis by virus isolation from bronchoalveolar lavage fluid or pleural fluid, and demonstration of inclusion bodies in cytological preparations. This is also the first series to report treatment with interferon omega (IFN-ω). Two cats survived, both of which had been treated with IFN-ω. As CPxV represents a serious zoonotic risk it is an important differential diagnosis of pneumonia in cats.
Introduction
Cowpox virus (CPxV) belongs to the Orthopoxvirus genus, and is endemic in northern Europe and western areas of the former Soviet Union. 1 Although called cowpox, it rarely infects cattle; disease is most common in domestic cats, with >400 cases having been reported. [2] [3] [4] [5] [6] However, infections are commonly missed by owners and veterinarians, so prevalence may be higher than documented. 5 The reservoir hosts are believed to be bank voles (Myodes glareolus), field voles (Microtus agrestis) and wood mice (Apodemus sylvaticus) as they have the highest prevalence of antibodies to CPxV. 7, 8 Cats are exposed to CPxV when hunting, 9 so there are more feline CPxV infections in the autumn when the host populations are at their most numerous. 2 The outcome of feline infection depends on CPxV strain, route and site of infection, dose of inoculated virus, 5 and presence of systemic immunosuppression; for example, concurrent feline immunodeficiency virus (FIV) or feline leukaemia virus (FeLV) infection, 2, 10 or the administration of systemic glucocorticoids. 2 CPxV infection most commonly presents as focal cutaneous lesions, which heal spontaneously, with no systemic signs. Concurrent oral lesions occur in approximately 20% of cats, 11 and occasional reports document severe, necrotising, sometimes fatal, cutaneous lesions. 12 Fatal necrotising pneumonia has been described in a small number of papers; [13] [14] [15] to our knowledge there has been only one case of CPxVassociated pneumonia that survived. 16 Although zoonotic transmission is rare, it is reported and can be potentially fatal. 3, [15] [16] [17] [18] [19] It is therefore important that CPxV infection be considered as a differential diagnosis in cases of pneumonia and/or dermatitis in cats.
This case series documents five cases of CPxV pneumonia in domestic cats, which were all referred for respiratory signs rather than cutaneous lesions. Two cases recovered; both received immunomodulatory therapy. Three cases died, two of which also received immunomodulatory therapy.
Materials and methods
Cytological examinations of lung fine-needle aspirates (FNAs), bronchoalveolar lavage (BALF) and pleural fluid from cases 1-4 were carried out on direct smears and fluid samples concentrated by cytocentrifugation (Cytospin 3; Thermo Fisher Scientific) followed by standard staining with May-Grünwald Giemsa. Cytological examinations of lung FNAs and BALF from case 5 were carried out following staining with modified Wrights (Hematek; Siemens) stain.
Biopsy and post-mortem tissue samples were fixed in 10% phosphate-buffered formalin (pH 7.4), embedded in paraffin wax, and sections (4 μm) stained with haematoxylin and eosin using routine methods.
Case series description
Case 1 A 4-year-old, neutered male Russian Blue cat was referred to the University of Edinburgh (UoE) in October 2002 after 5 days of inappetence and lethargy. The cat was vaccinated against feline calicivirus (FCV), feline herpesvirus-1 (FHV-1) and feline panleukopenia virus (FPV); it was a keen hunter.
The cat was dyspnoeic, with bilaterally harsh lung sounds and bilateral dullness on thoracic percussion. Multiple, 2-5 mm diameter, circumscribed, papular skin lesions were present on the head and neck, which became erythematous on palpation ( Figure 1 ).
Routine haematology and serum biochemistry were unremarkable except for a mature neutrophilia (43.35 × 10 9 /l; reference interval [RI] 7-20 × 10 9 /l) and increased urea (15.75 mmol/l; RI 5.71-12.85). Serum was negative for FeLV antigen, and FIV and feline coronavirus (FCoV) antibodies. Thoracic radiographs showed consolidation of the right cranial and middle lung lobes, and a low-volume effusion was also present. Pleural fluid cytology revealed a pyothorax containing mostly non-degenerate neutrophils, with some activated macrophages (occasionally containing phagocytosed neutrophils), mesothelial cells and a small number of variably sized lymphocytes. Bacterial culture was negative, including extended culture for Mycoplasma species. Histopathology of the skin lesions revealed extensive necrotising dermatitis with viral inclusions in the epidermis and panniculus. Electron microscopy identified poxvirus viral particles ( Figure 2 ).
The cat was given recombinant feline interferon omega (rFeIFN-ω; Virbagen Omega [Virbac] 1 MU/kg IV q24h); marbofloxacin (Marbocyl [Vetoquinol] 2 mg/kg IV q24h) and clindamycin (Dalacin [Pfizer] 10 mg/kg IV q12h).
When the dyspnoea worsened a median sternotomy and right cranial and middle lung lobectomy was performed. Lung histopathology revealed acute, fibrinous pneumonia with extensive alveolitis; numerous cytoplasmic inclusion bodies and multinucleated giant cells suggested a viral aetiology. Bacterial culture was sterile.
Complications led to euthanasia. Post-mortem examination revealed diffuse, severe pneumonia with many 6-10 mm diameter CPxV lesions on the surface of the lungs (Figure 3 ). Widespread vasculitis, lymphadenopathy and splenic histiocytosis were also present. Lung 
Case 2
In January 2009, a 2-year-old, neutered male Ragdoll cat was referred to the UoE with acute tachypnoea and coughing. The cat was vaccinated against FCV, FHV-1 and FPV, and was an avid hunter. It was tachypnoeic at 66 breaths per minute (bpm), had reduced chest compressibility and squeaks on pulmonary auscultation. A 6 mm diameter, ulcerated skin lesion was present over its left stifle area. Overnight, the cat developed, over its head, neck and thorax, 5-10 mm diameter, erythematous, ulcerated skin lesions with necrotic centres (Figure 4 ). Respiratory rate and effort increased.
Haematology revealed mild neutropenia (5.9 × 10 9 /l; RI 7-20 × 10 9 /l) and lymphopenia (0.9 × 10 9 /l; RI 1.5-7.0 × 10 9 /l). Serum biochemistry was unremarkable, and serum was negative for FeLV antigen and FIV antibodies. Thoracic radiography revealed consolidation of the right lung and the middle of the left lung (Figure 5a ,b). Ultrasonography confirmed severe consolidation of the right lung. A small, right-sided pleural effusion was evident. Thoracocentesis, bronchoalveolar lavage (BAL) and a FNA of the right lung were performed. Bronchoscopy showed severe hyperaemia of the airway.
Cytology of the lung aspirate revealed acute necrotising pneumonia with clumps of palely basophilic material (presumptive necrotic material), numerous non-degenerate neutrophils, and a few lymphocytes and macrophages. Alveolar epithelial cells showed anisocytosis, anisokaryosis and variably basophilic cytoplasm. Cytology of the pleural fluid revealed an exudate with reactive lymphocytes and large granular lymphocytes; it was sterile on bacterial culture. Cytology of BALF revealed numerous neutrophils, which were mainly degenerate, ciliated respiratory epithelial cells and occasional goblet cells consistent with acute neutrophilic bronchopneumonia with mucus hypersecretion. It was sterile on routine bacterial culture, and negative for Mycoplasma species; CPxV was isolated on extended viral culture. Skin histopathology showed severe necrotising ulcerative dermatitis with intracytoplasmic viral inclusion bodies, confirmed as CPxV on virus isolation.
The cat was treated with rFeIFN-ω (Virbagen Omega, 1 MU/kg SC q24h); terbutaline (Bricanyl [AstraZeneca] 0.015 mg/kg IV q4h); amoxicillin-clavulanate (Augmentin [GlaxoSmithKline] 20 mg/kg, IV q8h); clindamycin (Dalacin, 11 mg/kg IV q12h) and fluticasone/salmeterol inhaler (Seretide [GlaxoSmithKline] 2 puffs q12h). En largement of skin lesions ceased after 12 h of treatment. After 3 days, when the clinical signs were improving, the rFeIFN-ω and fluticasone/salmeterol were stopped. The cat returned home with a course of amoxicillin-clavulanate (Synulox [Zoetis] 20 mg/kg PO q12h) and clindamycin (Antirobe [Zoetis] 11 mg/kg PO q12h) in case a secondary infection had been missed. Complete recovery was achieved in 6 weeks. week's history of progressive dyspnoea, wheezing, coughing and anorexia. It was vaccinated against FCV, FHV-1 and FPV, and was a known hunter. The cat was markedly dyspnoeic, crackles and wheezes were auscultated over both lung fields and several small, nodular crusting skin lesions were present on the tail.
Haematology and serum biochemistry were unremarkable, and serum was negative for FeLV antigen, and FIV and Toxoplasma antibodies. Orthopox virus serology revealed the presence of antibodies (titre 1/128) consistent with acute infection. Poxvirus was cultured from a skin scab. Thoracic radiography revealed consolidation of the left cranial lung lobe; bronchoscopy revealed severe ulcerative tracheitis and bronchitis; BALF was submitted for FHV-1 PCR, FCV and CPxV isolation, routine culture and extended culture for Mycoplasma species; and oropharyngeal swabs were submitted for FHV-1, FCV and CPxV isolation. Prior to recovery from the anaesthesia, the cat received dexamethasone (Colvasone [Norbrook] 0.07 mg/kg IV) to reduce additional inflammation caused by bronchoscopy.
Poxvirus was isolated from the BALF and high levels of FHV-1 DNA were detected in the BALF by PCR, indicating active infection; Bordetella bronchiseptica was isolated. Poxvirus and FHV-1 were isolated from oropharyngeal swabs. Cytology of the BALF revealed chronic pyogranulomatous bronchopneumonia, with large numbers of non-degenerate neutrophils and macrophages.
The cat was diagnosed with bronchopneumonia caused by CPxV, FHV-1 and B bronchiseptica, and mild CPxV-associated dermatitis. It was treated with rFeIFN-ω (Virbagen Omega, 2.5MU/kg SC q48h); marbofloxacin (Marbocyl, 2 mg/kg IV q24h); clindamycin (Dalacin, 10 mg/kg IV q12h) and buprenorphine (Buprecare [Dechra Veterinary Products] 0.01 mg/kg IV q8h), and responded well to treatment. Repeat radiographs 3 days later demonstrated a marked improvement. The cat was discharged with marbofloxacin (Marbocyl, 2 mg/kg PO q24h) and clindamycin (Antirobe, 10 mg/kg PO q12h), and made a complete recovery over the following 3 weeks.
Case 4
A 4-year-old, neutered male DSH cat, who hunted regularly, was referred to the UoE in November 2009 with dyspnoea, coughing and anorexia. The cat was markedly dyspnoeic, with bilaterally increased lung sounds. Thoracic radiography showed consolidation of the entire left lung. Ultrasonography confirmed this, plus a small volume pleural effusion.
The cat was treated with oxygen, marbofloxacin (Marbocyl, 2 mg/kg IV q24h), clindamycin (Dalacin, 10 mg/kg IV q12h), amoxicillin-clavulanate (Augmentin, 20 mg/kg IV q8h), terbutaline (Bricanyl, 0.015 mg/kg IV q4h), dexamethasone (Colvasone, 0.1mg/kg IV q24h), buprenorphine (Buprecare, 0.01mg/kg IV q8h) and compound sodium lactate (Hartmann's solution, 5 ml/kg/h IV).
Five, slightly raised, 3-4 mm diameter, erythematous skin lesions were then seen over the left thoracic wall. A presumptive diagnosis of CPxV pneumonia was made, and the cat was given rFeIFN-ω (Virbagen Omega, 1 MU/kg IV q24h). Two skin lesions were biopsied for histopathology and CPxV isolation. Cytology of the pleural fluid revealed neutrophilic inflammation. Cytology of a lung FNA was consistent with an acute suppurative pneumonia. However, one large cell (suspected to be a ciliated respiratory epithelial cell) was seen with 2-3 large, round, amphophilic inclusions resembling cytoplasmic type A viral inclusions (Figure 6a ). This cell, and one other, had elongated structures extending from their cell surface, resembling the actin tails seen in poxvirus infections. In addition, one ciliated respiratory epithelial cell had a circular cluster of small round amphophilic structures resembling a type B inclusion, or possibly Mycoplasma species organisms. No bacteria were isolated.
The cat deteriorated and was euthanased. Postmortem examination confirmed severe unilateral interstitial pneumonia with bilateral fibrinous pleuritis and severe serosanguineous pleural effusion. Lung histopathology showed severe, diffuse, necrotising pneumonia with fibrinous pleuritis, syncytia and intracytoplasmic eosinophilic inclusion bodies ( Figure 6 ). These findings were consistent with CPxV pneumonia. Necrotising tracheitis and ulcerative dermatitis were also confirmed, both with intracytoplasmic inclusion bodies. Skin histopathology revealed severe, epidermal necrosis and ulceration with eosinophilic intracytoplasmic viral inclusions consistent with CPxV infection. Mycoplasma species was cultured from the pleural fluid, and CPxV was cultured from the skin biopsies and pleural fluid.
Case 5
In September 2014, a 10-year-old, neutered female, DSH cat was referred to the Emergency and Critical Care Department at the Royal Veterinary College with acute acute-onset respiratory distress. The cat was vaccinated against FCV, FHV-1 and FPV, and had access to the outdoors but was not known to hunt.
On presentation she was tachypnoeic but not dyspnoeic, with a respiratory rate of 102 bpm, and harsh lung sounds bilaterally. She was considered cardiovascularly stable. No skin lesions were present.
There were no significant abnormalities on venous blood gas, electrolyte and limited biochemistry analysis. Haematology revealed a moderate neutrophilia of 19.05 × 10 9 /l (RI 2.5-12.5 × 10 9 /l) with a left shift, and mild polychromasia despite a haematocrit within the RI (40.3%; RI 24-45%). Thoracic radiography revealed consolidation of the right caudal, middle and accessory lung lobes. There was no evidence of excess pleural fluid.
The cat was treated with compound sodium lactate (Hartmann's solution, 3 ml/kg/h IV), amoxicillinclavulanate (Augmentin, 20 mg/kg IV q8h) and oxygen nebulisation. The cat subsequently deteriorated significantly with regard to breathing rate and effort, and was mechanically ventilated for 24 h. Anaesthesia for Cytology of the BALF revealed marked neutrophilic inflammation; eosinophils were also present, and epithelial hyperplasia or dysplasia was observed. Bacterial culture of this fluid was negative. Cytology of a FNA taken from the right caudal lung lobe revealed a predominance of non-degenerate neutrophils with small numbers of lymphocytes and occasional macrophages. Moderate-to-large numbers of sheets of spindloid-to-round cells with a small amount of deeply basophilic cytoplasm and central dense nuclei (basal epithelial cells) were present. The remainder of the cells were cuboidal to columnar. Binucleate cells and occasional multinucleate cells were also observed. Occasional epithelial cells were observed containing medium-tolarge, globular, smooth, green/blue-appearing or amphophilic inclusions, which were suspected to be viral inclusions. Rare cells containing these inclusions had elongated structures consistent with those resembling actin tails as noted in case 4. Moderate-to-high numbers of goblet cells were also present.
A PCR was carried out on one of the lung aspirate smears and on the BALF, and a diagnosis of CPx Vinduced pneumonia was confirmed from both samples.
Owing to a lack of improvement and financial constraints, the cat was euthanased; a post-mortem examination was declined.
Discussion
To our knowledge this is the first case series of CPxVinduced pneumonia, with or without pleural effusion, in domestic cats. Single cases of fatal necrotising pneumonia have been documented previously in the Netherlands, Germany and the UK. [13] [14] [15] However, there has only been one report of CPxV-pneumonia (with concurrent FHV-1 infection), which recovered. 16 Cats are thought to become infected with CPxV while hunting wild rodents. 11 Four of the five cats in this series were known rodent hunters and 4/5 cases occurred in autumn, consistent with the peak in wild rodent populations. 11 In cats, the usual route of virus entry appears to be through the skin, resulting in a single primary skin lesion. Poxvirus viraemia may then lead to multiple secondary skin lesions, with fever, inappetence and pneumonia in severe cases. 11 Interestingly, the cats in this paper were all referred for the investigation of respiratory signs, with skin lesions only being found at or after presentation in four cases. A similar presentation was described by Johnson et al, 16 and skin lesions were never observed in another case of CPxV pneumonia. 14 The fact that only some cats develop pneumonia may relate to immunosuppression (FeLV, FIV or renal failure), concurrent bacterial infections, dose of inoculated virus and/or viral virulence. 2, 10, 20 Two of our cases (cases 3 and 4) received glucocorticoids at anti-inflammatory doses. The detrimental effects of glucocorticoids on CPxV infection have been reported previously so immunosuppressive doses are contraindicated. 2 However, in severe pneumonia, anti-inflammatory doses could be beneficial in relieving clinical signs. Although 2/5 cats had concurrent infections, it is unclear whether this predisposed to CPxV pneumonia and/or exacerbated it. Mycoplasma species was found in the pleural fluid of case 4, and this cat died. However, concurrent infection does not always result in severe disease. Cases of CPxV-associated dermatitis with concurrent FPV developed no systemic disease; 21 another case with concurrent canine distemper virus had only skin lesions; 22 and case 3 in the present report had CPxV pneumonia with FHV-1 and B bronchiseptica infections and still recovered. Based on this case series, and other reports, 16, 21 concurrent infections appear to be relatively common, which highlights the importance of identifying any concurrent infections so that treatment can be tailored to each case.
It is possible that our cats were infected with a virulent strain of CPxV, and they developed pneumonia. In Germany, several strains have been shown to exist; 23 but, as yet, there are no reports of feline-tropic variants in the UK. 24 While DNA sequencing was not performed in this series, it could be carried out in future cases to assess the possibility of a strain of CPxV with a higher virulence for cats.
Diagnosis of CPxV pneumonia can be made by a number of methods. There are no pathognomonic clinical signs, although concurrent skin lesions increase clinical suspicion. Lung consolidation may be seen on thoracic radiographs and/or ultrasound, often with a small pleural effusion, 14, 16 as seen in three cats of our study.
Ideally, all suspected CPxV infections should be confirmed by virus isolation. 11 In this series, for the first time, CPxV-associated pneumonia was confirmed by virus isolation from BALF or pleural fluid (cases 2, 3 and 4); previous studies have isolated virus from lung tissue at necropsy or skin lesions. 15, 16 This is of note as BAL and thoracocentesis are less invasive than lung biopsy. Virus isolation usually takes 2-3 days; 11 however, extended culture for up to 10 days is sometimes necessary, as in case 2.
A description of the cytology of BALF, pleural fluid or pulmonary aspirates does not appear to have been previously reported. It can reveal characteristic intracytoplasmic (type A) inclusion bodies, and, in case 4, occasional inclusion bodies were found in the lung cytology that appeared to be both type A and possibly type B inclusions. Type A, most commonly seen with CPxV, are protein-rich, with small numbers of virus particles at the periphery, while type B are designated 'virus factories', with many virions present. It was also of note that structures resembling actin tails were seen. These are a means to transfer virions between cells, and are typical of poxvirus infection. 25, 26 Histopathology of lung lesions can be useful. Previous reports describe necrotising proliferative bronchointerstitial pneumonia with segmental loss of respiratory epithelium, hypertrophy of type II pneumocytes, a marked infiltrate of neutrophils, macrophages, lymphocytes and plasma cells, fibrin accumulation within airways, and eosinophilic-to-amphophilic intracytoplasmic type A inclusions in airway epithelial cells with type II pneumocytes. 13, 14 Similar findings were present in cases 1 and 4. Histopathology and electron microscopy can help establish a rapid presumptive diagnosis but they do not confirm the identity of the virus. 27 Serum assays including virus neutralisation, haemagglutination inhibition, complement fixation and ELISA, can detect antibody to orthopoxvirus, 11 as in case 3, but a rising titre is required to prove active infection. 27 PCR is also a confirmatory test for CPxV infection, 9 and it can distinguish CPxV from other orthopox viruses. 15 The CPxV strains in this series were not classified by PCR.
Treatment is generally supportive. There are no antiviral drugs licensed to treat CPxV infection. 28 Historically, most cats with CPxV-pneumonia died despite supportive treatment. 13, 14, 28 In this series, rFeIFN-ω (Virbagen Omega) was used in four cases. It is an immunomodulatory drug with antiviral properties, 29 and the only IFN licensed in Europe for use in veterinary medicine. It is licensed for the treatment of cats with FeLV and/or FIVinfection (subcutaneous injection) and for dogs with canine parvovirus infection (intravenous injection); it also has in vitro antiviral activity against FHV-1, FCV and FCoV. 29, 30 While it is only licensed in the UK for cats by subcutaneous injection, it is licensed in Australasia and Japan for the treatment of acute FCV in cats by intravenous injection. As it is known to be safe in cats given intravenously (IV), and our cats with CPxV were seriously ill, we elected to give it by this route so that it could take effect as rapidly as possible.
In this series, four cats received rFeIFN-ω as soon as they were presumptively diagnosed with CPxV infection, and two recovered. It was considered highly likely that all would have died given the severity of disease, although this cannot be said for certain. Why treatment was only successful in two patients is unknown, although the others may have been too severely affected. 29 This case series suggests that rFeIFN-ω may be potentially useful in the treatment for CPxV-associated pneumonia and dermatitis in cats; however, further research is required before this can be confirmed. An optimal treatment regime is not known, although the manufacturer recommends 2.5 MU/kg every other day IV for three injections when treating acute FCV (data on company file), and 1 MU/kg q24h subcutaenously for 5 consecutive days for the treatment of FeLV infection, to be repeated on days 0, 14 and 60. 31 Other antiviral drugs could also be considered. The most promising antiviral in cats is famciclovir for the treatment of FHV-1 disease; 29 however, its efficacy against CPxV is unknown. Vidarabine has been shown to be effective against poxviruses in vitro, 32 and cidofovir has broad-spectrum activity against poxviruses in humans, and CPxV in vitro. 33 In cats, cidofovir has been used with good results for the topical treatment of FHV-1 ocular infections, 34 and, in vivo, it has shown to protect mice from a lethal CPxV respiratory infection. 33 However, more research in cats is needed as this drug has been shown to be nephrotoxic in humans.
Although CPxV infection is usually mild in healthy humans, 17, 18 severe and even fatal systemic disease can occur. 3, 15, 19 Clinical signs are usually pustular skin lesions on the hands but the face and eyelids can also be affected. 3 As cats are thought to be the main source of CPxV for humans, 3 cats with possible CPxV-infections should be treated as a zoonotic risk. It is advised that veterinary surgeons handling cats with suspect CPxV infections should wear gloves and avoid direct contact of lesion material with the eyes, nose and mouth, or with skin wounds.
Conclusions
This case series shows that, although an unusual presentation, CPxV-associated pneumonia may be a more common manifestation of CPxV-disease than previously believed. Owing to its potential zoonotic risk, CPxV infection must be considered as a differential diagnosis in cats with presenting signs of pneumonia with or without typical cutaneous lesions.
